Latest

neuropharmacology

This shows a photo of a woman with her face cut out

Featured Neurology Neuroscience Psychology

·April 3, 2019·2 min read

Psychostimulants play a major role in fatal strokes among young adults

Psychostimulant use in young adults is correlated with an increased risk of stroke.

This shows pills and a pestle and mortar

Featured Neurology

·April 2, 2019·2 min read

A “Low Dose Aspirin” for Dementia? Drug Ready for First in-Human Testing

MW-151, a new drug that blocks 'bad' inflammation in the brain is about to be tested in a new human trial. Researchers believe the new drug could help stave off dementia.

This is the chemical structure of ketamine

Featured Neuroscience Psychology

·March 30, 2019·4 min read

Researchers Discover How a Critical Receptor is Involved in the Response to Fast-Acting Antidepressants Like Ketamine

The mGlu2 receptor plays a critical role in the effectiveness of ketamine for treating depression.

this diagram shows how the drug combinations lead to apoptosis in brain cancer

Brain Cancer Featured Neurology Neuroscience

·March 22, 2019·4 min read

New drug combination shows promise for common pediatric brain tumor

Combining carboplatin, a common chemotherapy drug, with everolimus, a drug that blocks mTOR, is effective at inducing apoptosis and slowing tumor growth in patients with pediatric low-grade glioma brain cancer.

Featured Genetics Neuroscience Psychology

·March 22, 2019·4 min read

When neurons are out of shape, antidepressants may not work

Differences in serotonergic neuron morphology, along with altered gene expression have been identified in patients with MDD. The findings shed light on why some patients do not respond to SSRI antidepressants.

Featured Neurology Neuroscience Open Neuroscience Articles

·March 20, 2019·7 min read

New study reshapes understanding of how the brain recovers from injury

Retinal ganglion cell survival following a stroke depends on whether the pathway to the primary visual area remains active. Cells connected to inactive areas of the visual cortex suffer atrophy and degenerate, leading to permanent visual impairment.

Featured Neuroscience

·March 14, 2019·3 min read

Using an anti-smoking drug to control neurons

Study outlines a new ion channel based platform for cell activation which is controlled by low doses of the common anti-smoking drug, varenicline.

Featured Neuroscience

·February 27, 2019·4 min read

Study Reveals Structure of the Second Human Cannabinoid Receptor

Researchers have identified the structure of the human type 2 cannabinoid receptor. The findings, researchers say, can help in the development of new treatments for inflammatory and neurodegenerative diseases.

Featured Neurology Open Neuroscience Articles

·February 21, 2019·4 min read

Native California Medicinal Plant May Hold Promise for Treating Alzheimer’s

Salk researchers have discovered a possible neuroprotective and anti-inflammatory compound in the Californian shrub, Yerba santa, that may help in the treatment of Alzheimer's disease.

Featured Psychology

·February 20, 2019·5 min read

Some Drug Combinations More Effective Than Others For Patients with Schizophrenia

A new study reveals some drug combinations may be more beneficial for those with schizophrenia. Researchers found people with schizophrenia who took antidepressants, in combination with other medications, were less likely to be hospitalized for mental health issues than those who started another antipsychotic.

Featured Genetics Neuroscience Open Neuroscience Articles Psychology

·February 18, 2019·5 min read

Depression Reversed by Activating Gene That Helps Excite Neurons: Male Mouse Study

Researchers report activating the SIRT1 gene in male mice helped to reverse symptoms of depression, such as social isolation and loss of interest. The study suggests drugs that activate SIRT1 may be an effective therapy for some with major depression.

Featured Neurology

·February 15, 2019·4 min read

Statins Could Protect Against ALS

A new study reports high cholesterol may contribute to the risk of developing ALS. The findings suggest cholesterol lowering drugs, such as statins, could help to prevent the onsite of the neurodegenerative disease.